ArticleCureus2025
Distribution of Oncological Diagnoses in Pediatric Patients With Febrile Neutropenia and Sepsis: Is There an Association?
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Infections are a major complication in pediatric oncology, with patients at increased risk due to chemotherapy-induced neutropenia and compromised immune status. This retrospective study, conducted between 2018 and 2022 at the "Maria Sklodowska Curie" Children's Emergency Clinical Hospital in Bucharest, evaluated 150 episodes of fever and sepsis in 94 pediatric oncology patients. The results revealed significant differences between the groups analyzed: children with central nervous system tumors had a higher frequency of sepsis (p = 0.03), while patients with leukemia and lymphoma had the longest intervals between treatment initiation and fever onset. Also, profound neutropenia was more pronounced in patients with lymphomas (median neutrophil count = 0.18, p = 0.003). These results emphasize the need for personalized monitoring of infectious risk and adaptation of prophylaxis strategies according to the type of malignancy. In conclusion, the obtained data contribute to substantiating an individualized approach in the management of fever and sepsis in pediatric oncology patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.